Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Clinical Breast Cancer
Published September 17, 2026
Value of Breast and Axillary Tumor-Infiltrating Lymphocytes for Response to Neoadjuvant Chemo-(Im...
October 11, 2026
Medspoke
Medspoke
The Breast
Published October 7, 2026
00:00
--:--
Belgian validation of the INFLUENCE 3.0 model predicting 5-year locoregional and contralateral br...
October 11, 2026
Share
Belgian validation of the INFLUENCE 3.0 model predicting 5-year locoregional and contralateral breast cancer recurrence.
https://www.medspoke.co/channel_journal?id=795&tap_id=15400
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Clinical Colorectal Cancer
Published September 18, 2026
EGFR Targeting With Afatinib and Cetuximab Versus Cetuximab Alone in Chemorefractory Wild-type RA...
October 11, 2026
Why are you reporting this TALK?
